US › Healthcare

Shuttle Pharmaceuticals Inc (SHPH)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.65+8.31%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-2.2M
Profit YoY
+29.5%
EPS
$-4.28

Key statistics

Market cap
$2.2M
P/E
38.0
Forward P/E
0.0
P/B
0.66
Book value
$6.03
EPS (TTM)
$0.10
52-week high
$55.90
52-week low
$2.58
50-day MA
$4.00
200-day MA
$12.80
Beta
1.29

Shareholding

Insiders
6.30%
Institutions
12.88%

Largest institutional holders

FundStake
Ikarian Capital, LLC1.24%
Geode Capital Management, LLC0.83%
BOOTHBAY FUND MANAGEMENT, LLC0.37%
Virtu Financial LLC0.22%
UBS Group AG0.10%
Tower Research Capital LLC0.08%
Wall Street Access Asset Management, LLC0.01%
Morgan Stanley - Brokerage Accounts0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Shuttle Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.